Results 201 to 210 of about 875,282 (310)

Inflammation and Diabetic Kidney Disease. [PDF]

Int J Mol Sci
Zhang RM, Caramori ML.
europepmc   +1 more source

Electrochemiluminescence Drives Photodynamic Therapy In Vivo

Advanced Science, EarlyView.
Electrochemiluminescence (ECL)‐driven photodynamic therapy (PDT) for in vivo cancer treatment is reported for the first time. The flexible ECL patch exhibits stable and intense luminance under alternating current voltage, enabling efficient photosensitization to generate reactive oxygen species that damage cancer cells, thus leading to significant ...
Jia‐Bao Lin, Ling‐Ling Xu, Yong Liu, Hang Gao, Hong‐Yuan Chen, Jing‐Juan Xu   +5 more
wiley   +1 more source

Urinary biomarkers of diabetic kidney disease. [PDF]

World J Diabetes
Gembillo G, Soraci L, Messina R, Lo Cicero L, Spadaro G, Cuzzola F, Calderone M, Ricca MF, Di Piazza S, Sudano F, Peritore L, Santoro D.   +11 more
europepmc   +1 more source

Pancreatic transplantation using duct occlusion technique [PDF]

, 1988
Abendroth, D., Illner, Wolf-Dieter, Land, Walter, Landgraf, R.   +3 more
core   +1 more source

Navigating the Ethereal Tightrope: The Nanogenerator Manipulates Neurons for Immune Equilibrium

Advanced Science, EarlyView.
This review explores how nanogenerators modulate neuroimmune responses, offering innovative strategies for treating neurological disorders. By interfacing with neural pathways, they enable precise control of immune activity, especially via vagus nerve stimulation.
Jia Du, Rui Deng, Ya Wu, Hong‐Xia Ren, Zong‐Hong Lin, Yang‐Bao Miao   +5 more
wiley   +1 more source

The biology of PKM2 in the metabolism and senescence in diabetic kidney disease. [PDF]

J Diabetes Investig
Kayes MI, Kanasaki K.
europepmc   +1 more source

The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease.

Kidney International, 2022
Jia Fu, Zeguo Sun, Xuan Wang, Tuo Zhang, W. Yuan, F. Salem, Samuel Mon-Wei Yu, Weijia Zhang, Kyung Lee, J. He   +9 more
semanticscholar   +1 more source

Activating the Osteoblastic USP26 Pathway Alleviates Multi‐Organ Fibrosis by Decreasing Insulin Resistance

Advanced Science, EarlyView.
The loss of Ubiquitin Specific Peptidase 26 (USP26) in osteoblasts results in decreased bone formation, as well as multi‐organ fibrosis associated with insulin resistance (IR). Mechanistically, the absence of USP26 reduces glycolysis and lactate accumulation, leading to decreased histone H3 lysine 18 lactylation (H3K18LA) in the promoter region of KH ...
Jiyuan Tang, Wenkai Ye, Liang He, Zhou Dan, Leilei Chang, Zijie You, Yuanyue Jiang, Guoqing Tang, Lianfu Deng, Changwei Li   +9 more
wiley   +1 more source

miRNA in the Progression of Diabetic Kidney Disease: New Insight. [PDF]

Int J Mol Sci
Zou Z, Zhou N, Zhang C.
europepmc   +1 more source

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

EBioMedicine, 2019
L. Hickson, Larissa G P Langhi Prata, Shane A. Bobart, Tamara K. Evans, N. Giorgadze, Shahrukh K Hashmi, S. Herrmann, M. Jensen, Qingyi Jia, Kyra L. Jordan, T. Kellogg, S. Khosla, D. Koerber, A. Lagnado, Donna K. Lawson, N. LeBrasseur, L. Lerman, Kathleen M. McDonald, T. Mckenzie, J. Passos, R. Pignolo, T. Pirtskhalava, Ishran M Saadiq, Kalli Schaefer, S. Textor, Stella G. Victorelli, Tammie L. Volkman, A. Xue, M. Wentworth, Erin O. Wissler Gerdes, Yi Zhu, T. Tchkonia, J. Kirkland   +32 more
semanticscholar   +1 more source